These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29156740)

  • 1. Improvement of therapeutic effects of mesenchymal stem cells in myocardial infarction through genetic suppression of microRNA-142.
    Yang LX; Wei CL; Guo ML; Zhang Y; Bai F; Ma SG
    Oncotarget; 2017 Oct; 8(49):85549-85558. PubMed ID: 29156740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.
    Dakhlallah D; Zhang J; Yu L; Marsh CB; Angelos MG; Khan M
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):241-51. PubMed ID: 25658461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction.
    Yao X; Liu Y; Gao J; Yang L; Mao D; Stefanitsch C; Li Y; Zhang J; Ou L; Kong D; Zhao Q; Li Z
    Biomaterials; 2015 Aug; 60():130-40. PubMed ID: 25988728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-10a rejuvenates aged human mesenchymal stem cells and improves heart function after myocardial infarction through KLF4.
    Dong J; Zhang Z; Huang H; Mo P; Cheng C; Liu J; Huang W; Tian C; Zhang C; Li J
    Stem Cell Res Ther; 2018 May; 9(1):151. PubMed ID: 29848383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-206 is involved in survival of hypoxia preconditioned mesenchymal stem cells through targeting Pim-1 kinase.
    Zhang Y; Lei W; Yan W; Li X; Wang X; Zhao Z; Hui J; Shen Z; Yang J
    Stem Cell Res Ther; 2016 Apr; 7(1):61. PubMed ID: 27103465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair.
    Haider HKh; Jiang S; Idris NM; Ashraf M
    Circ Res; 2008 Nov; 103(11):1300-8. PubMed ID: 18948617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
    Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
    Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
    Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
    Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction.
    Ma J; Ge J; Zhang S; Sun A; Shen J; Chen L; Wang K; Zou Y
    Basic Res Cardiol; 2005 May; 100(3):217-23. PubMed ID: 15754085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of protein kinase C ɛ improves retention and survival of transplanted mesenchymal stem cells in rat acute myocardial infarction.
    He H; Zhao ZH; Han FS; Liu XH; Wang R; Zeng YJ
    Cell Death Dis; 2016 Jan; 7(1):e2056. PubMed ID: 26775707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction.
    Huang F; Li ML; Fang ZF; Hu XQ; Liu QM; Liu ZJ; Tang L; Zhao YS; Zhou SH
    Cardiology; 2013; 125(1):18-30. PubMed ID: 23615185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model.
    Shi B; Long X; Zhao R; Liu Z; Wang D; Xu G
    Exp Biol Med (Maywood); 2014 Mar; 239(3):356-65. PubMed ID: 24477823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the effects of MSCs and CD34+ cell therapy in a rat model of myocardial infarction.
    Shalaby SM; El-Shal AS; Zidan HE; Mazen NF; Abd El-Haleem MR; Abd El Motteleb DM
    IUBMB Life; 2016 May; 68(5):343-54. PubMed ID: 26949188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.
    Hahn JY; Cho HJ; Kang HJ; Kim TS; Kim MH; Chung JH; Bae JW; Oh BH; Park YB; Kim HS
    J Am Coll Cardiol; 2008 Mar; 51(9):933-43. PubMed ID: 18308163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-23a is involved in tumor necrosis factor-α induced apoptosis in mesenchymal stem cells and myocardial infarction.
    Mao J; Lv Z; Zhuang Y
    Exp Mol Pathol; 2014 Aug; 97(1):23-30. PubMed ID: 24269648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-378 promotes mesenchymal stem cell survival and vascularization under hypoxic-ischemic conditions in vitro.
    Xing Y; Hou J; Guo T; Zheng S; Zhou C; Huang H; Chen Y; Sun K; Zhong T; Wang J; Li H; Wang T
    Stem Cell Res Ther; 2014 Nov; 5(6):130. PubMed ID: 25418617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation.
    Bhakta S; Hong P; Koc O
    Cardiovasc Revasc Med; 2006; 7(1):19-24. PubMed ID: 16513519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.